Last reviewed · How we verify
Chronic Cluster Headache with Aura and Migraine without Aura Prevention — Treatment Landscape & Competitive Intelligence
1 marketed
0 Phase 3
0 Phase 2
Live · 30-min refresh
Marketed treatment landscape
| Drug | Generic | Sponsor | Class | Target | Line of therapy | First approval |
|---|---|---|---|---|---|---|
| PF-07976016 Formulation A | pf-07976016-formulation-a | Pfizer | Unknown | Unknown |
Phase 3 pipeline
Phase 2 pipeline
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Sponsor landscape
- Pfizer · 1 drug in Chronic Cluster Headache with Aura and Migraine without Aura Prevention
Subscribe to ongoing alerts
Every new regulatory action, PDUFA date, or trial completion in Chronic Cluster Headache with Aura and Migraine without Aura Prevention:
- Chronic Cluster Headache with Aura and Migraine without Aura Prevention treatment updates — RSS
- Chronic Cluster Headache with Aura and Migraine without Aura Prevention treatment updates — Atom
- Chronic Cluster Headache with Aura and Migraine without Aura Prevention treatment updates — JSON
Cite this brief
Drug Landscape (2026). Chronic Cluster Headache with Aura and Migraine without Aura Prevention — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/chronic-cluster-headache-with-aura-and-migraine-without-aura-prevention. Accessed 2026-06-10.
Related
- Chronic Cluster Headache with Aura and Migraine without Aura Prevention full disease profile — treatment pathway, diagnostics, guidelines
- Browse all CI briefs
- Build a custom feed
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing